Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
Publication

Publications

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

Title
Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
Type
Article in International Scientific Journal
Year
2019
Authors
Zannad, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ferreira, JP
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Pitt, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 21
Pages: A55-A60
ISSN: 1520-765X
Other information
Authenticus ID: P-00Q-AN5
Abstract (EN): New therapeutic options to treat hyperkalaemia, such as potassium binders, have been suggested as potentially beneficial by allowing the maintenance (or increase) of the dose of medications that improve outcomes in several cardiovascular conditions, but which have in common the propensity for raising serum potassium. However, potassium binding drugs have yet to prove their causal association with improvements in patients' prognosis before their widespread use can be recommended. In this review we provided an up-to-dare appraisal on potassium binders, their potential clinical applications and directions for future research.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach? (2017)
Another Publication in an International Scientific Journal
Ferreira, JP; Mentz, RJ; Pizard, A; Pitt, B; Zannad, F
Estimated Long-Term Survival With Eplerenone (2019)
Another Publication in an International Scientific Journal
Stienen, S; Ferreira, JP; Vincent, J; Busselen, M; Li, B; McMurray, JJ; Pitt, B; Girerd, N; Rossignol, P; Zannad, F
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial (2018)
Another Publication in an International Scientific Journal
Ferreira, JP; Barros, A; Pitt, B; Montalescot, G; Lopez de Sa, EL; Hamm, CW; Flather, M; Verheugt, F; Shi, H; Leite-Moreira AF; Vincent, J; Rossignol, P; Zannad, F
Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT (2021)
Article in International Scientific Journal
Ferreira, JP; Rossignol, P; Claggett, BL; Solomon, SD; Pitt, B; Pfeffer, M; Zannad, F
Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials (2018)
Article in International Scientific Journal
Ferreira, JP; Duarte, K; Pitt, B; Dickstein, K; McMurray, JJV; Zannad, F; Rossignol, P

See all (37)

Of the same journal

Essential Hypertension Predicted by Tracking of Elevated Blood Pressure from Childhood to Adulthood (1997)
Article in International Scientific Journal
Costa-Pereira A; Costa-Pereira A
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-28 at 14:38:29 | Privacy Policy | Personal Data Protection Policy | Whistleblowing